Literature DB >> 27766583

Optical Coherence Tomography Angiography in Diabetes.

Jessica Lee1, Richard Rosen2.   

Abstract

Diabetic retinopathy is a progressive microvascular disease that leads to increased vessel permeability, retinal ischemia, and retinal neovascularization. Optical coherence tomography angiography (OCTA) is a novel angiography technique that has the capability to advance our understanding of diabetic eye disease by providing high-resolution images of retinal and choroidal microvasculature blood flow and structure. Using OCTA, the vascular changes of diabetic retinopathy including microaneurysms, retinal non-perfusion, intraretinal microvascular abnormalities, and neovascularization can be clearly visualized. OCTA offers several advantages over fluorescein angiography (FA) in that it is faster, safer, and non-invasive, allows better visualization of retinal vessels in both the superficial and deep capillary layers, and can provide quantitative measurements of areas of non-perfusion of the macula and nerve. OCTA capillary perfusion density maps and average perfusion density values provide an easy way to grade progressive vascular change. Despite these advantages, imaging with OCTA can only provide a limited view of the peripheral retina and is unable to demonstrate leakage, staining, or pooling. OCTA requires patients to maintain good fixation to obtain high-resolution images which can be a challenge for those with severe macular disease. In patients who cannot safely undergo FA, OCTA may serve as an alternative form of angiography that can be safely and more frequently performed for the management of diabetic retinopathy.

Entities:  

Keywords:  Diabetes; Diabetic macular edema; Diabetic retinopathy; Diagnosis; OCT angiography; Staging

Mesh:

Year:  2016        PMID: 27766583     DOI: 10.1007/s11892-016-0811-x

Source DB:  PubMed          Journal:  Curr Diab Rep        ISSN: 1534-4827            Impact factor:   4.810


  30 in total

1.  Optical Coherence Tomography Angiography in Diabetic Retinopathy: A Prospective Pilot Study.

Authors:  Akihiro Ishibazawa; Taiji Nagaoka; Atsushi Takahashi; Tsuneaki Omae; Tomofumi Tani; Kenji Sogawa; Harumasa Yokota; Akitoshi Yoshida
Journal:  Am J Ophthalmol       Date:  2015-04-18       Impact factor: 5.258

2.  Undiagnosed NIDDM: clinical and public health issues.

Authors:  M I Harris
Journal:  Diabetes Care       Date:  1993-04       Impact factor: 19.112

3.  Grading diabetic retinopathy from stereoscopic color fundus photographs--an extension of the modified Airlie House classification. ETDRS report number 10. Early Treatment Diabetic Retinopathy Study Research Group.

Authors: 
Journal:  Ophthalmology       Date:  1991-05       Impact factor: 12.079

Review 4.  Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales.

Authors:  C P Wilkinson; Frederick L Ferris; Ronald E Klein; Paul P Lee; Carl David Agardh; Matthew Davis; Diana Dills; Anselm Kampik; R Pararajasegaram; Juan T Verdaguer
Journal:  Ophthalmology       Date:  2003-09       Impact factor: 12.079

5.  An autopsy case of fatal anaphylactic shock following fluorescein angiography: a case report.

Authors:  Masahito Hitosugi; Kazunobu Omura; Tomoko Yokoyama; Hitoshi Kawato; Yasuki Motozawa; Toshiaki Nagai; Shogo Tokudome
Journal:  Med Sci Law       Date:  2004-07       Impact factor: 1.266

6.  Diabetic retinopathy study. Report Number 6. Design, methods, and baseline results. Report Number 7. A modification of the Airlie House classification of diabetic retinopathy. Prepared by the Diabetic Retinopathy.

Authors: 
Journal:  Invest Ophthalmol Vis Sci       Date:  1981-07       Impact factor: 4.799

7.  Frequency of adverse systemic reactions after fluorescein angiography. Results of a prospective study.

Authors:  K A Kwiterovich; M G Maguire; R P Murphy; A P Schachat; N M Bressler; S B Bressler; S L Fine
Journal:  Ophthalmology       Date:  1991-07       Impact factor: 12.079

8.  The spectrum of superficial and deep capillary ischemia in retinal artery occlusion.

Authors:  Suqin Yu; Claudine E Pang; Yuanyuan Gong; K Bailey Freund; Lawrence A Yannuzzi; Ehsan Rahimy; Brandon J Lujan; Homayoun Tabandeh; Michael J Cooney; David Sarraf
Journal:  Am J Ophthalmol       Date:  2014-09-22       Impact factor: 5.258

9.  Optical coherence tomography angiography of the foveal avascular zone in diabetic retinopathy.

Authors:  Florentina J Freiberg; Maximilian Pfau; Juliana Wons; Magdalena A Wirth; Matthias D Becker; Stephan Michels
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-09-04       Impact factor: 3.117

Review 10.  Epidemiology of diabetic retinopathy, diabetic macular edema and related vision loss.

Authors:  Ryan Lee; Tien Y Wong; Charumathi Sabanayagam
Journal:  Eye Vis (Lond)       Date:  2015-09-30
View more
  27 in total

Review 1.  Imaging and Biomarkers in Diabetic Macular Edema and Diabetic Retinopathy.

Authors:  Changyow C Kwan; Amani A Fawzi
Journal:  Curr Diab Rep       Date:  2019-08-31       Impact factor: 4.810

2.  Correlation of vascular change and cognitive impairment in age-related macular degeneration patients.

Authors:  Yaoyan Qiu; Tingting Sun; Feijia Xu; Peng Gao; Guangyu Tang; Qing Peng
Journal:  Am J Transl Res       Date:  2021-01-15       Impact factor: 4.060

3.  Novel window for cancer nanotheranostics: non-invasive ocular assessments of tumor growth and nanotherapeutic treatment efficacy in vivo.

Authors:  Mayank Goswami; Xinlei Wang; Pengfei Zhang; Wenwu Xiao; Sarah J Karlen; Yuanpei Li; Robert J Zawadzki; Marie E Burns; Kit S Lam; Edward N Pugh
Journal:  Biomed Opt Express       Date:  2018-12-11       Impact factor: 3.732

4.  Correlations between visual acuity and macular microvasculature quantified with optical coherence tomography angiography in diabetic macular oedema.

Authors:  Chia-Chieh Hsiao; Chung-May Yang; Chang-Hao Yang; Tzyy-Chang Ho; Tso-Ting Lai; Yi-Ting Hsieh
Journal:  Eye (Lond)       Date:  2019-08-12       Impact factor: 3.775

5.  Comparison of Zeiss Cirrus and Optovue RTVue OCT Angiography Systems: A Quantitative and Qualitative Approach Examining the Three Capillary Networks in Diabetic Retinopathy.

Authors:  Christopher S Chung; Peter L Nesper; Justin J Park; Amani A Fawzi
Journal:  Ophthalmic Surg Lasers Imaging Retina       Date:  2018-11-01       Impact factor: 1.300

6.  Earliest Evidence of Preclinical Diabetic Retinopathy Revealed Using Optical Coherence Tomography Angiography Perfused Capillary Density.

Authors:  Richard B Rosen; Jorge S Andrade Romo; Brian D Krawitz; Shelley Mo; Amani A Fawzi; Rachel E Linderman; Joseph Carroll; Alexander Pinhas; Toco Y P Chui
Journal:  Am J Ophthalmol       Date:  2019-01-26       Impact factor: 5.258

7.  Comparisons Between Histology and Optical Coherence Tomography Angiography of the Periarterial Capillary-Free Zone.

Authors:  Chandrakumar Balaratnasingam; Dong An; Yoichi Sakurada; Cecilia S Lee; Aaron Y Lee; Ian L McAllister; K Bailey Freund; Marinko Sarunic; Dao-Yi Yu
Journal:  Am J Ophthalmol       Date:  2018-02-19       Impact factor: 5.258

8.  Reduced retinal vessel density in COVID-19 patients and elevated D-dimer levels during the acute phase of the infection.

Authors:  Noemi Guemes-Villahoz; Barbara Burgos-Blasco; Beatriz Vidal-Villegas; Juan Donate-López; Francisco Javier Martín-Sánchez; Jesús Porta-Etessam; Lorenzo López-Guajardo; José Luis R Martín; Juan Jorge González-Armengol; Julián García-Feijoó
Journal:  Med Clin (Engl Ed)       Date:  2021-06-05

9.  Is Diabetes Mellitus a Blessing in Disguise for Primary Open-angle Glaucoma?

Authors:  Huiyuan Hou; Sasan Moghimi; Sally L Baxter; Robert N Weinreb
Journal:  J Glaucoma       Date:  2021-01-01       Impact factor: 2.290

10.  Quantitative analysis of retinal vessel density and thickness changes in diabetes mellitus evaluated using optical coherence tomography angiography: a cross-sectional study.

Authors:  Xinyue Li; Yu Yu; Xueting Liu; Yan Shi; Xin Jin; Yanyan Zhang; Shuo Xu; Nan Zhang; Li Dong; Sujun Zhou; Yingbin Wang; Yiheng Ding; Zhen Song; Hong Zhang
Journal:  BMC Ophthalmol       Date:  2021-06-15       Impact factor: 2.209

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.